Statistics for Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Total visits
| views | |
|---|---|
| Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD) | 154 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| PHY2-8-e14434.pdf | 167 |
Top country views
| views | |
|---|---|
| United States | 133 |
| Canada | 2 |
| Germany | 2 |
| Ukraine | 2 |
| China | 1 |
| Malaysia | 1 |
| Russia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 49 |
| Fairfield | 27 |
| Cambridge | 9 |
| Houston | 5 |
| Ann Arbor | 4 |
| Lakewood | 3 |
| San Francisco | 3 |
| Jacksonville | 2 |
| Kiev | 2 |
| Toronto | 2 |
| Washington | 2 |
| Zion | 2 |
| Beijing | 1 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Kansas City | 1 |
| Kiez | 1 |
| Kuala Lumpur | 1 |
| Norwalk | 1 |
| Seattle | 1 |
| Stockholm | 1 |